This is a study to determine the effects of adding liraglutide to an existing treatment of rosiglitazone (Avandia) and metformin, and then to compare the three-drug combination to therapy with rosiglitazone and metformin alone. This international study is currently recruiting patients with Type 2 diabetes.
Read moreFull Question: I've suffered from migraines since I was about 5 years old, and I'm almost 56 now. I am currently on Relpax. How can I... Read more »
The drug metformin is not recommended for people with kidney disease. For this reason, some people think that metformin causes kidney... Read more »
I received an interesting question by e-mail recently, which brought up several good points to review. The author asked: "Can a patient... Read more »
A recent report again reaffirms that metformin is the first medication to use when a patient with type 2 diabetes (T2D) needs help with... Read more »
Metformin as well as every other prescription drug has a "label" (in the US, called a "United States package insert" or USPI, and in Europe... Read more »
This is a study to compare the safety and effectiveness of a combination of prandial inhaled insulin and metformin with the inhaled insulin and a... Read more »
June 7 - 13 is National Headache Awareness Week (NHAW) this year. A host of educational events and programs are happening around the country... Read more »
Metformin may lower diabetics' risk of pancreatic cancer by up to 60 percent, a new study suggests. Read more »
U.S. researchers say the diabetes drug Metformin is safe for patients with advanced heart failure. In a study of 401 diabetic patients with the... Read more »
The diabetes drug metformin has shown success in treating breast cancer when paired with common chemotherapy drugs, a mouse study suggests.... Read more »